Literature DB >> 27509379

Transfusion Therapy in Children With Sickle Cell Disease.

Adlette Inati1, Anthony G Mansour, Toni Sabbouh, Ghid Amhez, Ahmad Hachem, Hussein A Abbas.   

Abstract

Hydroxyurea, blood transfusions, and hematopoietic stem cell transplantation represent the 3 disease-modifying therapies in children with sickle cell disease (SCD). Blood transfusions play an increasingly important role in both prevention and management of SCD complications in this age group. This review will focus on the indications of blood transfusion in children with SCD and modalities of its administration. It will also highlight the complications of this life-saving therapy and ways of optimizing transfusion to minimize its associated risks.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27509379     DOI: 10.1097/MPH.0000000000000645

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease.

Authors:  Anna M Hood; Allison A King; Melanie E Fields; Andria L Ford; Kristin P Guilliams; Monica L Hulbert; Jin-Moo Lee; Desiree A White
Journal:  Pediatr Blood Cancer       Date:  2019-07-03       Impact factor: 3.167

Review 2.  Indications for transfusion in the management of sickle cell disease.

Authors:  Hyojeong Han; Lisa Hensch; Venée N Tubman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Blood Transfusion Frequency and Indications in Yemeni Children with Sickle Cell Disease.

Authors:  Abdul-Wahab M Al-Saqladi; Dikra M Maddi; Aida H Al-Sadeeq
Journal:  Anemia       Date:  2020-08-24

Review 4.  Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease.

Authors:  Thamal Darshana; David Rees; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.